Robert J Kurman

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

Tian-Li Wang, Jinghui Zhang, Kentaro Nakayama, 2012, Journal of the National Cancer Institute.

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Steven J Skates, Richard G. Moore, R. Bast, 2010, American journal of obstetrics and gynecology.

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

Ie-Ming Shih, I. Shih, R. Roden, 2008, American journal of obstetrics and gynecology.

Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations.

Tian-Li Wang, Chung-Liang Ho, Ie-Ming Shih, 2005, Cancer research.

Notch3 gene amplification in ovarian cancer.

Tian-Li Wang, Kentaro Nakayama, Ben Davidson, 2006, Cancer research.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Joakim Dillner, Daron G Ferris, Susanne K Kjaer, 2010, Journal of the National Cancer Institute.

Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study

Kirsten Frederiksen, Susanne K Kjaer, Russell Vang, 2020, International journal of cancer.

Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis.

Hsueh-Wei Chang, Ie-Ming Shih, I. Shih, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.

Giovanni Parmigiani, Tian-Li Wang, Kentaro Nakayama, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.

Lori J Sokoll, Hsueh-Wei Chang, Daniel W Chan, 2003, Journal of the National Cancer Institute.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Cosette M Wheeler, Diane M Harper, Mark H Stoler, 2005, The Lancet. Oncology.

Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications

Ie-Ming Shih, I. Shih, R. Kurman, 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.